arthritis

A new study reported by ScienceDaily suggests glucosamine, a widely used joint supplement taken by millions for arthritis and cartilage pain, may be associated with faster progression of Alzheimer's disease. The findings challenge the supplement's generally assumed safety benefits and are prompting discussion among researchers, patients and caregivers about whether people with cognitive decline should reconsider taking it.

New research suggests glucosamine, a widely used joint supplement taken by millions for arthritis and cartilage health, may be associated with faster progression of Alzheimer's disease. The finding is striking because the over-the-counter remedy has long been considered safe, and it raises fresh questions about supplement safety in older adults. Coverage is drawing attention from patients and clinicians alike.

Researchers report the identification of a new biological mechanism that drives osteoarthritis, the world's most common joint disease. The finding, covered by science news outlets, could open fresh avenues for treating a condition that currently has few options beyond pain management and, eventually, joint replacement surgery.